These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3158689)

  • 21. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
    Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM
    Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure.
    Amin DK; Shah PK; Hulse S; Shellock F
    Am Heart J; 1985 May; 109(5 Pt 1):1006-12. PubMed ID: 3158182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic effects of a constant intravenous infusion of piroximone in patients with severe congestive heart failure.
    Miller WE; Kennedy GT; Ruberg SJ; O'Rourke RA; Crawford MH
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):72-7. PubMed ID: 2459538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure.
    Uretsky BF; Verbalis JG; Generalovich T; Valdes A; Reddy PS
    Am J Physiol; 1985 Mar; 248(3 Pt 2):H396-402. PubMed ID: 3156513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure.
    Axelrod RJ; De Marco T; Dae M; Botvinick EH; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1124-30. PubMed ID: 3571752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute hemodynamic effects of MDL 19205 in mild congestive heart failure.
    Cottier C; Follath F; Kiowski W; Pfisterer M; Emmenegger H; Burkart F
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):209-12. PubMed ID: 2436000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
    Weber KT; Janicki JS; Jain MC
    J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure.
    Nicod P; Waeber B; Bussien JP; Goy JJ; Turini G; Nussberger J; Hofbauer KG; Brunner HR
    Am J Cardiol; 1985 Apr; 55(8):1043-7. PubMed ID: 3885704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and long-term hemodynamic response to low-dose enoximone in refractory heart failure.
    McDonald KM; O'Sullivan JJ; McWilliams EW; Conroy RC; Maurer BJ
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):913-8. PubMed ID: 2535057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations.
    DiCarlo L; Chatterjee K; Parmley WW; Swedberg K; Atherton B; Curran D; Cucci M
    J Am Coll Cardiol; 1983 Nov; 2(5):865-71. PubMed ID: 6313787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.
    Simonton CA; Chatterjee K; Cody RJ; Kubo SH; Leonard D; Daly P; Rutman H
    J Am Coll Cardiol; 1985 Aug; 6(2):453-9. PubMed ID: 4019930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemodynamic, anti-ischemic, metabolic and neurohumoral effects of enoximone (MDL 17,043) in patients with coronary disease].
    Mitrovic V; Schlepper M; Neuzner J; Bahavar H; Volz M; Dieterich HA
    Z Kardiol; 1988 Oct; 77(10):660-7. PubMed ID: 2977029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dose-response relation of intravenous enoximone in congestive cardiac insufficiency].
    Lellouche D; Delorme G; Merlet P; Dubois-Randé JL; Duval AM; Tarral A; Bourdarias JP; Vernant P
    Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1107-13. PubMed ID: 2973777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological effects of intravenous MDL 17.043.
    Pop T; Treese N; Cremer GM; Haegele KD; Meyer J
    Int J Cardiol; 1986 Aug; 12(2):223-32. PubMed ID: 2943683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    Am J Cardiol; 1987 Aug; 60(5):68C-71C. PubMed ID: 2956872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
    de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure.
    Rauch B; Zimmermann R; Kapp M; Haass M; Von Molitor S; Smolarz A; Neumann FJ; Kübler W; Dietz R; Tillmanns H
    Clin Cardiol; 1991 May; 14(5):386-95. PubMed ID: 2049889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy.
    Weber KT; Janicki JS; Jain MC
    Am J Cardiol; 1986 Sep; 58(7):589-95. PubMed ID: 2944369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Continuous enoximone infusion in patients with severe heart failure in dilated cardiomyopathy, hemodynamic, neurohumoral, chemical laboratory and clinical results].
    Neuzner J; Mitrovic V; Pitschner HF; Lissmann H; Schlepper M
    Z Kardiol; 1991 Jun; 80(6):397-403. PubMed ID: 1681628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acute response of plasma norepinephrine, renin activity, and arginine vasopressin to short-term nitroprusside and nitroprusside withdrawal in patients with congestive heart failure.
    Francis GS; Olivari MT; Goldsmith SR; Levine TB; Pierpont G; Cohn JN
    Am Heart J; 1983 Dec; 106(6):1315-20. PubMed ID: 6359844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.